Advertisement

Topics

Elizabeth Iorns elected to the Board of Directors DCAT

15:48 EST 15 Nov 2017 | CentreWatch

Science Exchange, a secure enterprise platform for outsourced research and development (R&D) services, announced that Elizabeth Iorns, Ph.D., CEO of Science Exchange, has been elected to serve her first term on the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT) beginning November 1, 2017. Members of DCAT’s Board of Directors are […]

The post Elizabeth Iorns elected to the Board of Directors DCAT appeared first on CenterWatch News Online.

Original Article: Elizabeth Iorns elected to the Board of Directors DCAT

NEXT ARTICLE

More From BioPortfolio on "Elizabeth Iorns elected to the Board of Directors DCAT"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...